Mumbai (Maharashtra) [India], September 22: Glenmark Pharmaceuticals Limited ("Glenmark Pharma"), a research-led, integrated, global pharmaceutical company has entered into a definitive agreement with Nirma Limited to divest 75% stake in its subsidiary, Glenmark Life Sciences Limited ("GLS")
Mumbai (Maharashtra) [India]/ Mahwah (New Jersey) [US], August 17: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, integrated, global pharmaceutical company has received the final approval from the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Ointment, 0.0
Mumbai (Maharashtra) [India], August 12: Glenmark Pharmaceuticals Limited (Glenmark), an integrated, research-led, global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2023.
Mumbai (Maharashtra) [India], August 3: Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led, global pharmaceutical company has joined hands with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions f
Addressing the India-Dominican Republic Business Event in the Dominican Republic, Jaishankar said, "So this is very much, therefore, a diplomatic trip. It is a political trip, but it is, ofcourse, a business trip. Where the Dominican Republic is concerned from a trade we had of USD 12 mil
It is a fixed-dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg), and is available as a ready-to-dilute IV injection. It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con
Glenmark's Nicardipine Hydrochloride capsules of 20 mg and 30 mg will be distributed in the US by Glenmark Pharmaceuticals US, according to a statement from Glenmark.
The BSE 30-share Sensex declined 393 points to 61,787.77 levels and 50-share Nifty went down 112 points to 18,496.60 levels at 9.20 in the morning. Some of the gainers on BSE during morning trade were Hindustan Oil Exploration, Hikal and JP Associates. MTNL, Raymond, Glenmark and BirlaSoft w
London [UK]/ Mahwah (New Jersey) [US], Mumbai (Maharashtra) [India], August 31 (ANI/PRNewswire): Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) - an innovation driven gl
Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2022.
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee